# Epintek

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/epintek

- Industry: Healthcare
- Headquarters: Guiyang, China
- Total disclosed funding: $16M
- Latest round: Series C (Aug 28, 2023)
- Investors on record: 7

## About

Established in 2020 and based in Guiyang, China, Epintek is a medical device technology service platform that provides inspection and testing and contract research and development outsourcing CRO (contract research organization) services. The company is mainly involved in the field of medical equipment and biomedicine. The company's operation center is located in Shanghai, the biomedical laboratory is located in Suzhou, the electrical medical and wireless communication laboratory is located in Suzhou Industrial Park and the biomedical research, development, and testing center is located in Guiyang. In August 2023, Epintek raised series C3 funding from new investor Oct Capital.

The company provides pre-clinical research, inspection and testing, regulatory registration, and clinical trials CRO (contract research organization) services for customers. Besides, the company provides medical equipment electrical safety testing, performance testing, EMC electromagnetic compatibility, animal testing, chemical characterization, microbial testing, biocompatibility, cleaning, disinfection and sterilization verification, packaging aging, and physical and chemical performance services for customers.

The company earned profits from CRO services, mainly including medical equipment clinical trials, and testing services.

## Funding rounds

- Series C, Aug 28, 2023 — October Capital
- Series C, Jan 30, 2022, $16M — Furong Capital, Qianshan Capital, Guiyang Venture Capital
- Series C, Oct 8, 2021 — Oriental Fortune Capital, MED-FINE Capital, Guiyang Venture Capital
- Series B, Mar 3, 2021 — Oriental Fortune Capital, Button Capital, Guiyang Venture Capital
- Series B, Nov 2, 2020 — Button Capital
- Series B, May 21, 2020 — Guiyang Venture Capital

## Investors

- Guiyang Venture Capital (https://capitalatlas.ai/funds/guiyang-venture-capital) — Series B, Series C
- Button Capital (https://capitalatlas.ai/funds/button-capital) — Series B
- Oriental Fortune Capital (https://capitalatlas.ai/funds/oriental-fortune-capital) — Series B, Series C
- MED-FINE Capital (https://capitalatlas.ai/funds/med-fine-capital) — Series C
- Furong Capital (https://capitalatlas.ai/funds/furong-capital) — Series C
- Qianshan Capital — Series C
- October Capital (https://capitalatlas.ai/funds/october-capital) — Series C